株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

感染症用POC (ポイント・オブ・ケア) の世界市場:2015〜2019年

Global POC Infectious Diseases Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 329261
出版日 ページ情報 英文 72 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
感染症用POC (ポイント・オブ・ケア) の世界市場:2015〜2019年 Global POC Infectious Diseases Market 2015-2019
出版日: 2015年04月29日 ページ情報: 英文 72 Pages
概要

感染症のためのPOC診断は患者の治療現場の近くで行なわれる診断検査で、診断と治療との間の時間を短縮することを目的としています。世界の感染症用POC市場は2014〜2019年にかけCAGR7.50%で拡大すると見込まれています。

当レポートでは、世界の感染症用POC市場について調査し、市場の動向と今後の成長見通し、市場の課題、主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 当レポートの範囲

第4章 市場調査方法

第5章 イントロダクション

第6章 概要

第7章 院内感染

第8章 在宅ケア検査

  • 概要
  • 在宅ケアの種類

第9章 市場環境

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第10章 疾患別市場セグメンテーション

  • RSV
  • インフルエンザ
  • アデノウイルス
  • マラリア
  • レンサ球菌性菌血症
  • 結核
  • 潜血
  • HIV
  • 感染性単核球症

第11章 地域別セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第12章 購買基準

第13章 市場成長促進因子

第14章 促進因子とその影響

第15章 市場の課題

第16章 促進因子の影響と課題

第17章 市場動向

第18章 動向とその影響

第19章 ベンダー環境

  • 競合シナリオ
  • 主要ベンダー
  • その他の特筆すべきベンダー

第20章 主要ベンダー分析

  • Alere
  • Meridian
  • OraSure
  • Trinity Biotech

第21章 当シリーズの他のレポート

目次
Product Code: IRTNTR5761

About POC infectious diseases

POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. The testing site is usually a patient's bedside, physician's clinic, ICU, operating room, emergency room, or wherever medical care may be necessary. A healthcare professional or a nurse attending the patient will obtain the specimen, perform analysis, and record the result. The main purpose of POC testing is to decrease the time between diagnosis and treatment. This test is either antibody-based or microbial particle-based detection method, which includes ELISA, agglutination, optical immunoassays, or lateral flow immunochromatography. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies. Performing this test for screening infectious diseases extends its applications to the community practice setting. For instance, processing accurate data on the prevalence of influenza in community could help curtail inappropriate use of antibacterial agents and improve the allocation of vaccines to areas of highest need.

Technavio's analysts forecast the global POC infectious disease market to grow at a CAGR of 7.50% over the period 2014-2019.

Covered in this report

The report covers the present scenario and the growth prospects of the global POC infectious disease market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of testing kits and devices used for the major POC infectious diseases in the market. Based on diseases, the market can be divided into 10: flu, tuberculosis, malaria, RSV, adenovirus, infectious mononucleosis, fecal occult blood, HIV, strep. B, others (HCV, HBV, giardia, syphilis, and pneumonia).

Technavio's report, the Global POC Infectious Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the global POC infectious disease market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Alere
  • Meridian Bioscience
  • Orasure Technologies
  • Trinity Biotech

Other Prominent Vendors

  • Abbott
  • Beckman Coulter/ Danaher
  • Becton Dickinson
  • Biomerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • Diasorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/ Innogenetics
  • Grifols/ Novartis Diagnostics
  • Humor Diagnostica
  • Hologic/ Gen-Probe
  • Nanogen/ Elitech
  • Ortho-Clinical Diagnostics/ Johnson & Johnson
  • Qiagen
  • Roche Diagnostics
  • SeraCare
  • Siemens Healthcare
  • Thermo Fisher Scientific

Market driver

  • Increase in prevalence of infectious diseases
  • For a full, detailed list, view our report

Market challenge

  • Lack of awareness about POC devices
  • For a full, detailed list, view our report

Market trend

  • Shift from physician-centered to patient-centered model
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

1. Executive Summary

2. List of Abbreviations

3. Scope of the Report

  • 3.1. Market overview
  • 3.2. Product offerings

4. Market Research Methodology

  • 4.1. Market research process
  • 4.2. Research methodology

5. Introduction

6. Overview

7. Hospital-acquired Infections

8. Homecare Testing

  • 8.1. Overview
  • 8.2. Types of homecare

9. Market Landscape

  • 9.1. Market overview
  • 9.2. Market size and forecast
  • 9.3. Five forces analysis

10. Market Segmentation by Diseases

    • 10.1.1. RSV
    • 10.1.2. Flu
    • 10.1.3. Adenovirus
    • 10.1.4. Malaria
    • 10.1.5. Strep B
    • 10.1.6. Tuberculosis
    • 10.1.7. Fecal occult blood
    • 10.1.8. HIV
    • 10.1.9. Infectious mononucleosis

11. Geographical Segmentation

  • 11.1. POC infectious diseases market in Americas
    • 11.1.1. Market size and forecast
  • 11.2. POC infectious diseases market in EMEA
    • 11.2.1. Market size and forecast
  • 11.3. POC infectious diseases market in APAC
    • 11.3.1. Market size and forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive scenario
    • 19.1.1. Key news
    • 19.1.2. Mergers and acquisitions
  • 19.2. Market share analysis 2014
  • 19.3. Other prominent vendors

20. Key Vendor Analysis

  • 20.1. Alere
    • 20.1.1. Key facts
    • 20.1.2. Business overview
    • 20.1.3. Business segmentation by revenue 2013
    • 20.1.4. Business segmentation by revenue 2012 and 2013
    • 20.1.5. Geographical segmentation by revenue 2013
    • 20.1.6. Business strategy
    • 20.1.7. Recent developments
    • 20.1.8. SWOT analysis
  • 20.2. Meridian
    • 20.2.1. Key facts
    • 20.2.2. Business overview
    • 20.2.3. Business segmentation by revenue 2014
    • 20.2.4. Business segmentation by revenue 2013 and 2014
    • 20.2.5. Geographical segmentation by revenue 2014
    • 20.2.6. Business strategy
    • 20.2.7. Recent developments
    • 20.2.8. SWOT analysis
  • 20.3. OraSure
    • 20.3.1. Key facts
    • 20.3.2. Business overview
    • 20.3.3. Product segmentation
    • 20.3.4. Business segmentation by revenue 2014
    • 20.3.5. Business segmentation by revenue 2013 and 2014
    • 20.3.6. Geographical segmentation by revenue 2014
    • 20.3.7. Business strategy
    • 20.3.8. Recent developments
    • 20.3.9. SWOT analysis
  • 20.4. Trinity Biotech
    • 20.4.1. Key facts
    • 20.4.2. Business overview
    • 20.4.3. Business segmentation by revenue 2013
    • 20.4.4. Business segmentation by revenue 2012 and 2013
    • 20.4.5. Geographical segmentation by revenue 2013
    • 20.4.6. Business strategy
    • 20.4.7. Recent developments
    • 20.4.8. SWOT analysis

21. Other Reports in this Series

List Of Exhibits

  • Exhibit 1: Market research methodology
  • Exhibit 2: POC testing market segmentation
  • Exhibit 3: Categorization of infectious diseases
  • Exhibit 4: HAIs in US
  • Exhibit 5: Estimated treatment cost and mortality associated with HAIs
  • Exhibit 6: Segmentation of HAI
  • Exhibit 7: Global POC infectious diseases market 2014-2019 ($ million)
  • Exhibit 8: Segmentation of market by disease types 2014
  • Exhibit 9: Regional malaria deaths
  • Exhibit 10: Regional malaria cases
  • Exhibit 11: WHO regional tuberculosis statistics
  • Exhibit 12: Demographic statistics for HIV
  • Exhibit 13: POC infectious diseases market by geography 2014
  • Exhibit 14: POC infectious diseases market by geography 2019
  • Exhibit 15: Segmentation of global POC infectious diseases market by geography 2014-2019
  • Exhibit 16: POC infectious diseases market in Americas 2014-2019 ($ million)
  • Exhibit 17: POC infectious diseases market in EMEA 2014-2019 ($ million)
  • Exhibit 18: POC infectious diseases market in APAC 2014-2019 ($ million)
  • Exhibit 19: Global POC Infectious Diseases Market: business segmentation by revenue 2013
  • Exhibit 20: Global POC Infectious Diseases Market: business segmentation by revenue 2012 and 2013 ($ billion)
  • Exhibit 21: Global POC Infectious Diseases Market: geographical segmentation by revenue 2013
  • Exhibit 22: Meridian: business segmentation by revenue 2014
  • Exhibit 23: Meridian: business segmentation by revenue 2013 and 2014 ($ million)
  • Exhibit 24: Meridian: geographical segmentation by revenue 2014
  • Exhibit 25: OraSure: product segmentation
  • Exhibit 26: OraSure: business segmentation by revenue 2014
  • Exhibit 27: OraSure: business segmentation by revenue 2013 and 2014 ($ million)
  • Exhibit 28: OraSure: geographical segmentation by revenue 2014
  • Exhibit 29: Trinity Biotech: business segmentation by revenue 2013
  • Exhibit 30: Trinity Biotech: business segmentation by revenue 2012 and 2013 ($ million)
  • Exhibit 31: Trinity Biotech: geographical segmentation by revenue 2013
Back to Top